Item 4. Controls and Procedures
ITEM 4. CONTROLS AND PROCEDURES
Management’s Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our
principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures, as
defined in Rules 13a-15(e) or 15d-15(e) under the Exchange Act, as of the end of the period covered by this quarterly report. Disclosure
controls and procedures are designed to ensure that information required to be disclosed by a company in the reports that it files or
submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules
and forms. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable
assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of
possible controls and procedures. Our management, including our principal executive officer and principal financial officer, after evaluating
the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report, concluded that as of such
date, certain of our disclosure controls and procedures were not effective, due to the material weaknesses in our internal controls over
financial reporting as described in our financial statements for the year ended December 31, 2022, as filed on Form 8-K/A on April 7,
2023.
Management noted a material weakness in our internal
control over financial reporting related to the understatement of unit-based compensation expense. The understatement of the grant
date fair value was due to a revision in the underlying fair value determination, and such revision was not appropriately reflected in
the financial statements. Management concluded that the grant date fair value and corresponding incremental expense should be adjusted
by recognizing the additional expense in Intermediate’s March 31, 2022 financials. As part of such process, management identified
a material weakness in its internal control over financial reporting related to the grant date fair value revision. Additionally, Intermediate
did not maintain effective internal control regarding the date on which to apply new accounting standards based upon CENAQ’s elections
made as an emerging growth company under the JOBS Act, which required Intermediate to apply new accounting standards as if it were a public
business entity.
Remediation Efforts to Address Disclosed
Material Weakness
Effective internal controls are necessary to provide
reliable financial reports and prevent fraud, and material weaknesses could limit the ability to prevent or detect a misstatement of accounts
or disclosures that could result in a material misstatement of annual or interim financial statements. Our management continues to evaluate
steps to remediate the material weaknesses. These material weaknesses have not been fully remediated. We are in the early stages of designing
and implementing a plan to remediate the material weaknesses identified. Our plan includes the below:
●
Designing and implementing a risk assessment process supporting the identification of risks facing the Company.
●
Implementing controls to enhance our review of significant accounting transactions and other new technical accounting and financial reporting issues and preparing and reviewing accounting memoranda addressing these issues.
●
Hiring additional experienced accounting, financial reporting and internal control personnel and changing roles and responsibilities of our personnel as we transition to being a public company and are required to comply with Section 404 of the Sarbanes Oxley Act of 2002.
●
Implementing controls to enable an accurate and timely review of accounting records that support our accounting processes and maintain documents for internal accounting reviews.
We cannot assure you that these measures will
significantly improve or remediate the material weaknesses described above. The implementation of these remediation measures is in the
early stages and will require validation and testing of the design and operating effectiveness of our internal controls over a sustained
period of financial reporting cycles and, as a result, the timing of when we will be able to fully remediate the material weaknesses is
uncertain and we may not fully remediate these material weaknesses during the year ended December 31, 2023. If the steps we take
do not remediate the material weaknesses in a timely manner, there could be a reasonable possibility that these control deficiencies or
others may result in a material misstatement of our annual or interim financial statements that would not be prevented or detected on
a timely basis. This, in turn, could jeopardize our ability to comply with our reporting obligations, limit our ability to access the
capital markets and adversely impact our stock price.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over
financial reporting during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect,
our internal control over financial reporting.
29
PART II OTHER INFORMATION
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.